These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23211837)

  • 1. Ipilimumab activity in advanced uveal melanoma.
    Khattak MA; Fisher R; Hughes P; Gore M; Larkin J
    Melanoma Res; 2013 Feb; 23(1):79-81. PubMed ID: 23211837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.
    Zimmer L; Vaubel J; Mohr P; Hauschild A; Utikal J; Simon J; Garbe C; Herbst R; Enk A; Kämpgen E; Livingstone E; Bluhm L; Rompel R; Griewank KG; Fluck M; Schilling B; Schadendorf D
    PLoS One; 2015; 10(3):e0118564. PubMed ID: 25761109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma.
    Maio M; Danielli R; Chiarion-Sileni V; Pigozzo J; Parmiani G; Ridolfi R; De Rosa F; Del Vecchio M; Di Guardo L; Queirolo P; Picasso V; Marchetti P; De Galitiis F; Mandalà M; Guida M; Simeone E; Ascierto PA
    Ann Oncol; 2013 Nov; 24(11):2911-5. PubMed ID: 24067719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.
    Danielli R; Ridolfi R; Chiarion-Sileni V; Queirolo P; Testori A; Plummer R; Boitano M; Calabrò L; Rossi CD; Giacomo AM; Ferrucci PF; Ridolfi L; Altomonte M; Miracco C; Balestrazzi A; Maio M
    Cancer Immunol Immunother; 2012 Jan; 61(1):41-8. PubMed ID: 21833591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A major responder to ipilimumab and nivolumab in metastatic uveal melanoma with concomitant autoimmunity.
    Chan PY; Hall P; Hay G; Cohen VML; Szlosarek PW
    Pigment Cell Melanoma Res; 2017 Jan; 30(6):558-562. PubMed ID: 28640512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ipilimumab in melanoma.
    Specenier P
    Expert Rev Anticancer Ther; 2012 Dec; 12(12):1511-21. PubMed ID: 23181437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-PD-1 antibodies in metastatic uveal melanoma: a treatment option?
    Bender C; Enk A; Gutzmer R; Hassel JC
    Cancer Med; 2017 Jul; 6(7):1581-1586. PubMed ID: 28639409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 2 study of tremelimumab in patients with advanced uveal melanoma.
    Joshua AM; Monzon JG; Mihalcioiu C; Hogg D; Smylie M; Cheng T
    Melanoma Res; 2015 Aug; 25(4):342-7. PubMed ID: 26050146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveal melanoma.
    Spagnolo F; Caltabiano G; Queirolo P
    Cancer Treat Rev; 2012 Aug; 38(5):549-53. PubMed ID: 22270078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Immune Checkpoint Blockade in Uveal Melanoma.
    Wessely A; Steeb T; Erdmann M; Heinzerling L; Vera J; Schlaak M; Berking C; Heppt MV
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of pembrolizumab for the treatment of metastatic uveal melanoma.
    Kottschade LA; McWilliams RR; Markovic SN; Block MS; Villasboas Bisneto J; Pham AQ; Esplin BL; Dronca RS
    Melanoma Res; 2016 Jun; 26(3):300-3. PubMed ID: 26848796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review.
    Heppt MV; Steeb T; Schlager JG; Rosumeck S; Dressler C; Ruzicka T; Nast A; Berking C
    Cancer Treat Rev; 2017 Nov; 60():44-52. PubMed ID: 28881222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
    Nathan P; Hassel JC; Rutkowski P; Baurain JF; Butler MO; Schlaak M; Sullivan RJ; Ochsenreither S; Dummer R; Kirkwood JM; Joshua AM; Sacco JJ; Shoushtari AN; Orloff M; Piulats JM; Milhem M; Salama AKS; Curti B; Demidov L; Gastaud L; Mauch C; Yushak M; Carvajal RD; Hamid O; Abdullah SE; Holland C; Goodall H; Piperno-Neumann S;
    N Engl J Med; 2021 Sep; 385(13):1196-1206. PubMed ID: 34551229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM).
    Rozeman EA; Prevoo W; Meier MAJ; Sikorska K; Van TM; van de Wiel BA; van der Wal JE; Mallo HA; Grijpink-Ongering LG; Broeks A; Lalezari F; Reeves J; Warren S; van Thienen JV; van Tinteren H; Haanen JBAG; Kapiteijn E; Blank CU
    Melanoma Res; 2020 Jun; 30(3):252-260. PubMed ID: 31895753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
    Weber JS; D'Angelo SP; Minor D; Hodi FS; Gutzmer R; Neyns B; Hoeller C; Khushalani NI; Miller WH; Lao CD; Linette GP; Thomas L; Lorigan P; Grossmann KF; Hassel JC; Maio M; Sznol M; Ascierto PA; Mohr P; Chmielowski B; Bryce A; Svane IM; Grob JJ; Krackhardt AM; Horak C; Lambert A; Yang AS; Larkin J
    Lancet Oncol; 2015 Apr; 16(4):375-84. PubMed ID: 25795410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of sunitinib malate in patients with metastatic uveal melanoma.
    Mahipal A; Tijani L; Chan K; Laudadio M; Mastrangelo MJ; Sato T
    Melanoma Res; 2012 Dec; 22(6):440-6. PubMed ID: 23114504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of immune checkpoint inhibitors and novel immunotherapies in uveal melanoma.
    Jindal V
    Chin Clin Oncol; 2018 Feb; 7(1):8. PubMed ID: 29486567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).
    Kelderman S; van der Kooij MK; van den Eertwegh AJ; Soetekouw PM; Jansen RL; van den Brom RR; Hospers GA; Haanen JB; Kapiteijn E; Blank CU
    Acta Oncol; 2013 Nov; 52(8):1786-8. PubMed ID: 23607756
    [No Abstract]   [Full Text] [Related]  

  • 19. Uveal melanoma: natural history and treatment options for metastatic disease.
    Wöll E; Bedikian A; Legha SS
    Melanoma Res; 1999 Dec; 9(6):575-81. PubMed ID: 10661768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Mayo Clinic experience with the use of kinase inhibitors, ipilimumab, bevacizumab, and local therapies in the treatment of metastatic uveal melanoma.
    Moser JC; Pulido JS; Dronca RS; McWilliams RR; Markovic SN; Mansfield AS
    Melanoma Res; 2015 Feb; 25(1):59-63. PubMed ID: 25396683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.